CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L107. A total of 25 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bracebridge Capital, LLC | 2,002,495 | $2,984,000 | 0.22% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 90,000 | $134,000 | 0.00% |
Virtu Financial LLC | 20,353 | $30,000 | 0.00% |
Verition Fund Management LLC | 30,000 | $45,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 40 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 33,915 | $50,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 39,228 | $58,000 | 0.00% |
CITIGROUP INC | 7,400 | $11,000 | 0.00% |
Renaissance Technologies | 34,700 | $52,000 | 0.00% |